MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 37 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,000 | +22.2% | 2,700 | -3.6% | 0.00% | – |
| Q2 2020 | $9,000 | -57.1% | 2,800 | -58.2% | 0.00% | -100.0% |
| Q4 2019 | $21,000 | -64.4% | 6,699 | -49.1% | 0.00% | -66.7% |
| Q3 2019 | $59,000 | +1.7% | 13,154 | +37.0% | 0.00% | 0.0% |
| Q2 2019 | $58,000 | +65.7% | 9,600 | +92.0% | 0.00% | +50.0% |
| Q1 2019 | $35,000 | -5.4% | 5,000 | +8.7% | 0.00% | -33.3% |
| Q1 2018 | $37,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rise Advisors, LLC | 272 | $4,108 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 318,995 | $4,826,394 | 0.00% |
| Covestor Ltd | 106 | $0 | 0.00% |
| Farther Finance Advisors, LLC | 77 | $0 | 0.00% |
| JBF Capital, Inc. | 39,637 | $1,189 | 0.00% |
| GOLDMAN SACHS GROUP INC | 29,807 | $450,980 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 15 | $0 | 0.00% |
| CWM, LLC | 22 | $0 | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 7,458 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 2,480 | $37,519 | 0.00% |